Overview
Support Groups
Latest News
Events
Clinical Trials
Hypophosphatasia
-
Jan 30, 2019 finreviewer.com
$1.61 EPS Expected for Alexion Pharmaceuticals, Inc. (ALXN); Abeona Therapeutics (ABEO) Shorts Decreased By 1.94% – The FinReviewer
Read More -
Jan 30, 2019 finreviewer.com
Comparison of Alexion Pharmaceuticals Inc. (ALXN) and Incyte Corporation (NASDAQ:INCY) – The FinReviewer
Read More -
Jan 30, 2019 hinewulm.com
Alexion Pharmaceuticals Inc. (ALXN) and Mirati Therapeutics Inc. (NASDAQ:MRTX) Comparing side by side – The Hi New Ulm
Read More -
Jan 30, 2019 finheadlines.com
Infinity Pharmaceuticals Inc. (INFI)’s Financial Results Comparing With Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) – The FinHeadLines
Read More -
Jan 29, 2019 hinewulm.com
Contrasting of Neptune Wellness Solutions Inc. (NEPT) and Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) – The Hi New Ulm
Read More -
Jan 29, 2019 finexaminer.com
Assurant (AIZ) to pay $0.60 on Mar 18, 2019; Alexion Pharmaceuticals (ALXN)’s Sentiment Is 1.04 – The FinExaminer
Read More -
Jan 28, 2019 whatsonthorold.com
Alexion Pharmaceuticals Inc (NASDAQ:ALXN): Institutional Investor Sentiment Down to 1.04 | Thorold News – Thorold News
Read More -
Jan 28, 2019 hinewulm.com
Alexion Pharmaceuticals, Inc. (ALXN) Reaches $118.34 After 6.00% Down Move; DC-Capital Advisors LTD Has Lifted By $2.90 Million Its Allegheny Technologies (ATI) Stake – The Hi New Ulm
Read More -
Jan 28, 2019 www.directorstalkinterviews.com
Alexion Pharmaceuticals, Inc. – Consenus Indicates Potential 39.2% Upside – DirectorsTalk Interviews
Read More
